State of Wyoming’s ADMA Biologics ADMA Stock Holding History

State of Wyoming’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$549K	Buy	60,978 +25,744	+73%	+$406K	0.07%	271
2025 Q4	$643K	Buy	+35,234	New	+$594K	0.07%	253
2025 Q2	–	Sell	-9,545	Closed	-$189K	–	1840
2025 Q1	$189K	Buy	+9,545	New	+$165K	0.03%	836
2024 Q4	–	Sell	-8,761	Closed	-$175K	–	1591
2024 Q3	$175K	Sell	8,761 -23,693	-73%	-$368K	0.03%	798
2024 Q2	$363K	Sell	32,454 -7,389	-19%	-$62K	0.06%	228
2024 Q1	$263K	Sell	39,843 -12,541	-24%	-$68.5K	0.04%	422
2023 Q4	$237K	Buy	52,384 +42,785	+446%	+$158K	0.04%	451
2023 Q3	$34.4K	Sell	9,599 -4,620	-32%	-$17.8K	0.01%	1352
2023 Q2	$52.5K	Sell	14,219 -26,895	-65%	-$99.7K	0.02%	1140
2023 Q1	$136K	Buy	+41,114	New	+$142K	0.04%	588
2022 Q1	–	Sell	-11,679	Closed	-$16K	–	1769
2021 Q4	$16K	Buy	+11,679	New	+$15.4K	0.01%	1555

Other funds holding ADMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State of Wyoming's ADMA Position: Q1 2026 in Review

State of Wyoming increased its ADMA Biologics (ADMA) stake by 73% in Q1 2026, buying an estimated $406K and bringing the position to 60,978 shares worth $549K. The position accounts for 0.07% of the portfolio, ranked #271.

State of Wyoming first reported a position in ADMA in Q4 2021 and has held it in 11 quarters since. The position peaked at $643K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

State of Wyoming held 60,978 shares of ADMA Biologics worth $549K as of Q1 2026.
State of Wyoming bought 25,744 ADMA Biologics shares in Q1 2026, an estimated $406K.
ADMA Biologics made up 0.07% of State of Wyoming's portfolio in Q1 2026, its #271 holding.
State of Wyoming first reported a position in ADMA Biologics in Q4 2021 and has held it in 11 quarters since.
State of Wyoming's ADMA Biologics position peaked at $643K in Q4 2025.
356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.